M1 Kliniken AGMKLNF 92 PS Ratio is 0.54 as of Jul. 06, 2026, which is 53% below its 10-year median of 1.15. GuruFocus rates MKLNF with a GF Score™ of 92/100 and a GF Value™ of $9.84. The stock has 4 warning signs investors should review. Among 116 Medical Distribution companies, M1 Kliniken AG ranks worse than 73.28% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, M1 Kliniken AG's share price is $11.7284.
M1 Kliniken AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $21.63. Hence, M1 Kliniken AG's PS Ratio for today is 0.54.
Warning Sign:
M1 Kliniken AG stock PS Ratio (=1.02) is close to 2-year high of 1.12.
The historical rank and industry rank for M1 Kliniken AG's PS Ratio or its related term are showing as below:
MKLNF'
s PS Ratio Range Over the Past 10 Years
Min: 0.25 Med: 1.15 Max: 5.63
Current: 1.02
During the past 12 years, M1 Kliniken AG's highest PS Ratio was 5.63. The lowest was 0.25. And the median was 1.15.
MKLNF's PS Ratio is ranked worse than 73.28% of 116
companies
in the Medical Distribution industry
Industry Median: 0.42
vs MKLNF: 1.02
M1 Kliniken AG has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of M1 Kliniken AG was 7.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 8.50% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 12.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 28.00% per year.
During the past 12 years, M1 Kliniken AG's highest 3-Year average Revenue per Share Growth Rate was 60.40% per year. The lowest was 2.50% per year. And the median was 23.30% per year.
Back to Basics: PS Ratio
M1 Kliniken AG (OTCPK:MKLNF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
M1 Kliniken AG PS Ratio Related Terms
M1 Kliniken AG PS Ratio Historical Data
* Premium members only.
The historical data trend for M1 Kliniken AG's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, M1 Kliniken AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's PS Ratio distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
M1 Kliniken AG's Share Price of today is $11.7284.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. M1 Kliniken AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $21.63.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
M1 Kliniken AG (MKLNF) has a PS Ratio of 0.54 as of Jul. 06, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on M1 Kliniken AG and its competitors. This is 53% below median its historical median of 1.15. Over the past decade, M1 Kliniken AG's PS Ratio has ranged from 0.25 to 5.63. According to the industry distribution chart, M1 Kliniken AG ranks #85 out of 116 companies in the Medical Distribution industry, placing it in the top 73.3%.
Is M1 Kliniken AG's PS Ratio too high?
M1 Kliniken AG's current PS Ratio of 0.54 is 53% below median its 10-year median of 1.15. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 5.63. The Medical Distribution industry median PS Ratio is 0.42. M1 Kliniken AG's value of 0.54 is 28.6% above this industry median. Based on the distribution chart, M1 Kliniken AG ranks #85 out of 116 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, M1 Kliniken AG has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's PS Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, M1 Kliniken AG ranks #85 out of 116 companies for PS Ratio. This places M1 Kliniken AG in the lower half of its industry. The industry median PS Ratio is 0.42. M1 Kliniken AG's value of 0.54 is 28.6% above this benchmark. Historically, M1 Kliniken AG's own PS Ratio has ranged from 0.25 to 5.63 over the past decade. While the company's 10-year median is 1.15 vs. the industry median of 0.42, M1 Kliniken AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.42, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M1 Kliniken AG's current PS Ratio of 0.54 is 28.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on M1 Kliniken AG and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M1 Kliniken AG's current PS Ratio is 0.54, which is 53% below median its own 10-year median of 1.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
M1 Kliniken AG (MKLNF) has a current PS Ratio of 0.54. The stock's GF Value™ is $9.84, compared to a current price of $11.73 — trading 19.2% above its estimated fair value. The current PS Ratio is 0.54, which is 53% below median its 10-year median of 1.15 and 28.6% above the Medical Distribution industry median of 0.42. M1 Kliniken AG's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For M1 Kliniken AG (MKLNF), the current PS Ratio is 0.54 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M1 Kliniken AG (MKLNF) Overvalued in 2026?
Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued.
The current stock price of $11.73 is trading 19.2% above its estimated GF Value™ of $9.84.
Key valuation signals for MKLNF:
PS Ratio: 0.54 (53% below median its 10-year median of 1.15)
GF Value™: $9.84 vs. price of $11.73 (19.2% above fair value)
Industry Position: 28.6% above the Medical Distribution median (#85 of 116)
No single metric tells the full story. See the MKLNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
92GF Score
Get the complete analysis for MKLNF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MKLNF has been successfully added to your 
